Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
48 studies found for:    Open Studies | "Sarcoidosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Sarcoidosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Worldwide Sarcoidosis Research Study
Condition: Sarcoidosis
Intervention:
2 Recruiting Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Condition: Sarcoidosis
Intervention:
3 Recruiting Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Conditions: Sarcoidosis;   Pulmonary Sarcoidosis
Intervention: Drug: Acthar gel
4 Recruiting Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)
Condition: Sarcoidosis
Intervention: Genetic: Genetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING
5 Recruiting The Lung Microbiome in Sarcoidosis
Condition: Sarcoidosis
Interventions: Other: Blood draw;   Procedure: Bronchoscopy;   Behavioral: Questionnaires
6 Recruiting Pulmonary Rehabilitation in Patients With Sarcoidosis
Condition: Stage 4 Pulmonary Sarcoidosis
Intervention: Other: Pulmonary rehabilitation program
7 Recruiting Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
Condition: Sarcoidosis
Intervention: Drug: Indium-111 Pentreotide
8 Recruiting RCT Comparing 21 and 22 G Needle in the Diagnosis of Sarcoidosis by EBUS TBNA
Condition: Sarcoidosis
Interventions: Other: 21 G needle group;   Other: 22 G needle group
9 Recruiting Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis
Condition: Sarcoidosis
Interventions: Procedure: 10 revolutions;   Procedure: 20 revolutions
10 Recruiting Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study
Condition: Sarcoidosis
Interventions: Drug: Habitrol;   Drug: Placebo to Habitrol
11 Recruiting A Trial to Compare Two Methods of Obtaining Tissue for Diagnosis of Sarcoidosis Namely the Conventional Method or the Ultrasound Guided Method
Condition: Sarcoidosis
Interventions: Other: cTBNA without ROSE;   Other: cTBNA with ROSE;   Other: EBUS-TBNA without ROSE;   Other: EBUS-TBNA with ROSE
12 Recruiting Cardiac Sarcoidosis Multi-Center Prospective Cohort
Condition: Cardiac Sarcoidosis
Intervention:
13 Not yet recruiting A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid
Condition: Sarcoidosis
Interventions: Device: GENEActiv Original Accelerometer;   Device: ActiGraph GT3X Accelerometer
14 Recruiting CNS Sarcoidosis and Acthar Gel
Condition: CNS Sarcoidosis
Intervention: Drug: H.P. Acthar Gel
15 Recruiting A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis
Condition: Sarcoidosis
Interventions: Device: Cup forceps;   Device: Alligator forceps
16 Recruiting Somatostatin Receptor Imaging in Cardiac Sarcoidosis
Condition: Cardiac Sarcoidosis
Intervention: Drug: Cu-64 DOTATATE
17 Recruiting Riociguat for Sarcoidosis Associated Pulmonary Hypertension
Condition: Sarcoidosis
Interventions: Drug: Riociguat;   Drug: Placebo
18 Available 18F-FDG PET Imaging in Cardiac Sarcoidosis
Condition: Cardiac Sarcoidosis
Intervention: Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT
19 Not yet recruiting ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
Conditions: Sarcoidosis;   Cutaneous Sarcoidosis
Interventions: Drug: ACTHAR Gel 40 units twice weekly;   Drug: ACTHAR Gel 80 units twice weekly.
20 Not yet recruiting Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
Condition: Pulmonary Sarcoidosis
Interventions: Drug: ACZ885;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.